Patents/Inventors

Gabriel Martinez Botella

Wayland, MAUS45 patents

42 Patents

US126178142026
Neuroactive Steroids and Methods of Use Thereof
SAGE THERAPEUTICS, LLC
0 cites
US125838492026
KCNT1 Inhibitors and Methods of Use
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US125527972026
Process for Making (3-[cyclopropylethoxy(difluoro)methyl]-6-6[5-fluoro-6-(2,2,2-trifluoroethoxy-3-pyridyl]- [1,2,4]triazolo[4,3-a]pyrazine
Praxis Precision Medicines, Inc.
0 cites
US125401572026
Oxysterols and Methods of Use Thereof
Sage Therapeutics, LLC
0 cites
US124798442025
Ion Channel Modulators
Praxis Precision Medicines, Inc.
0 cites
US124733272025
Neuroactive Steroids, Compositions and Uses Thereof
Sage Therapeutics, LLP
0 cites
US124484092025
Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US124042972025
Salts and Crystal Forms of GABA- a Positive Allosteric Modulator
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US123446152025
Substituted Pyridines as Ion Channel Modulators
Praxis Precision Medicines, Inc.
0 cites
US123310702025
C7 Substituted Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US123257112025
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an Ion Channel Modulator
Praxis Precision Medicines, Inc.
0 cites
US122686972025
Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US122016402025
19-nor C3,3-disubstituted C21-n-pyrazolyl Steroids and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US121802482024
Compositions and Methods for Treating CNS Disorders
Sage Therapeutics, Inc.
0 cites
US121802472024
Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US121459392024
Substituted [1,2,4]triazolo[4,3-a]pyrazines as Ion Channel Modulators
Praxis Precision Medicines, Inc.
0 cites
US121292762024
Oxysterols and Methods of Use Thereof
SAGE THERAPEUTICS, Inc.
0 cites
US120714532024
Neuroactive Steroids, Compositions, and Uses Thereof
Sage Therapeutics, Inc.
0 cites
US120654632024
Compositions and Methods for Treating CNS Disorders
Sage Therapeutics, Inc.
0 cites
US120308812024
Ion Channel Modulators
Praxis Precision Medicines, Inc.
0 cites
US119936282024
C7, C12, and C16 Substituted Neuroactive Steroids and Their Methods of Use
Sage Therapeutics, Inc.
0 cites
US119458362024
Compositions and Methods for Treating CNS Disorders
Sage Therapeutics, Inc.
0 cites
US119266462024
C7 Substituted Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US119185712024
Compounds and Their Methods of Use
Praxis Precision Medicines, Inc.
0 cites
US119127372024
19-nor Neuroactive Steroids and Methods of Use Thereof
Sage Therpeutics, Inc.
0 cites
US119053092024
Neuroactive Steroids and Methods of Use Thereof
SAGE THERAPEUTICS, Inc.
0 cites
US118846972024
Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US118789952024
Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US118664392024
Ion Channel Modulators
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US118514572023
Oxysterols and Methods of Use Thereof
SAGE THERAPEUTICS
0 cites
US117808752023
Neuroactive Steroids, Compositions, and Uses Thereof
Sage Therapeutics, Inc.
0 cites
US117730992023
Compounds and Their Methods of Use
Praxis Precision Medicines, Inc.
0 cites
US117730882023
KCNT1 Inhibitors and Methods of Use
Praxis Precision Medicines, Inc.
0 cites
US117673252023
Substituted [1,2,4]triazolo[4,3-a]pyrazines as Ion Channel Modulators
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US117319762023
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an Ion Channel Modulator
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US117319782023
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an Ion Channel Modulator
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US117320002023
Oxysterols and Methods of Use Thereof
Sage Therapeutics, Inc.
0 cites
US117319662023
Compounds and Their Methods of Use
PRAXIS PRECISION MEDICINES, Inc.
0 cites
USRE0495002023
Pyrrole Inhibitors of ERK Protein Kinase, Synthesis Thereof and Intermediates Thereto
VERTEX PHARMACEUTICALS INCORPORATED
0 cites
US116291462023
Substituted [1,2,4]triazolo[4,3-a]pyrazines as Modulators of Sodium Channel Activity
PRAXIS PRECISION MEDICINES, Inc.
0 cites
US116135562023
Oxysterols and Methods of Use Thereof
SAGE THERAPEUTICS, Inc.
0 cites
US115422972023
Compositions and Methods for Treating CNS Disorders
Sage Therapeutics, Inc.
0 cites